e 4031 has been researched along with Long QT Syndrome 1 in 1 studies
E 4031: class III anti-arrhythmia agent; structure given in UD
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ziupa, D | 1 |
| Menza, M | 1 |
| Koppermann, S | 1 |
| Moss, R | 1 |
| Beck, J | 1 |
| Franke, G | 1 |
| Perez Feliz, S | 1 |
| Brunner, M | 1 |
| Mayer, S | 1 |
| Bugger, H | 1 |
| Koren, G | 1 |
| Zehender, M | 1 |
| Jung, BA | 1 |
| Seemann, G | 1 |
| Foell, D | 1 |
| Bode, C | 1 |
| Odening, KE | 1 |
1 other study available for e 4031 and Long QT Syndrome 1
| Article | Year |
|---|---|
Electro-mechanical (dys-)function in long QT syndrome type 1.
Topics: Action Potentials; Animals; Animals, Genetically Modified; Anti-Arrhythmia Agents; Biomechanical Phe | 2019 |